BioPharmaceuticals Medical, AstraZeneca, Cambridge, UKLondon, United Kingdom
Disclosure information not submitted.
Using QBA in the Selection of Computable Operational Definitions to Minimize Misclassification & Underpower in RWE Studies
Monday, August 26, 20245:45 PM – 6:00 PM CEST